Fundraising Fox

Tom Woiwode

Investor

Managing Director at Versant Ventures

San Francisco, California

Writes $100K – $5M checks · typically $1.5M

About

Tom Woiwode is a PhD medicinal chemist with operating experience as CBO/COO who led IPOs/M&A exits including CRISPR Therapeutics and co-founds companies early with academics like Jim Wilson (iECURE).

LinkedIn ↗

Invests in

BiotechHealthtechMedical Devices

Experience

  1. Versant VenturesManaging Directorcurrent2014 — present
  2. Versant VenturesVenture Partner2005 — 2014
  3. Versant VenturesAssociate/Principal2002 — 2005
  4. OkairosChief Operating Officer2011 — 2013
  5. FlexionChief Business Officer2008 — 2010
  6. SynosiaChief Business Officer2006 — 2008
  7. AmiraChief Business Officer2005 — 2006
  8. XenoPortResearch Scientist2000 — 2002

Education

  1. Stanford UniversityPhD, Chemistry1995 — 2000
  2. University of California, BerkeleyBS, Chemistry1989 — 1993

Same school

Also attended Stanford University1,575

Peter ThielCo-founder & Partner at Founders FundReid HoffmanCo-founder of LinkedIn; Partner at GreylockDavid SacksCo-founder & General Partner at Craft Ventures; former White House AI & Crypto CzarKeith RaboisManaging Director at Khosla VenturesGarry TanPresident & CEO of Y CombinatorAlfred LinPartner at Sequoia Capital

+ 1,569 more

Also attended University of California, Berkeley863

Byron DeeterPartner at Bessemer Venture PartnersTrevor OelschigInvestment Team at General CatalystBrendan Bulik-SullivanInvestor at GV (Google Ventures)Glen AndersonPartner at Monta Vista CapitalAnthony LinHead of Intel Capital, Corporate Vice President at Intel CapitalScott ShawChief of Staff at Intel Capital

+ 857 more

Shared employers

Also worked at Versant Ventures29

David AllisonManaging Director at Westlake Village BioPartnersKristin BeachCFO at Theory VenturesJerel DavisManaging Director at Versant VenturesAlex MaywegManaging Director at Versant VenturesClare OzawaManaging Director at Versant VenturesCarlo RizzutoManaging Director at Versant Ventures

+ 23 more

Deals · 1

Bright Peak TherapeuticsBoard seat

via Versant Ventures · filed Jun 2024 · $90M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Versant Ventures

Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Managing Director at Versant Ventures
Bill Link
Investor at Versant Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures